{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:05:39Z","timestamp":1778047539033,"version":"3.51.4"},"reference-count":22,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["AR 19677786"],"award-info":[{"award-number":["AR 19677786"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>This article highlights a case of high-dose ferric carboxymaltose (Ferinject\u00ae) for the treatment of perioperative iron deficiency anaemia in a 39-year-old patient with dysplastic coxarthrosis. The patient was admitted routinely for a total hip replacement of the left hip joint. She had been suffering from pain, lameness, and restriction of movement in her left hip joint for the past several years. The patient was admitted with initial iron deficiency anaemia of a medium severity (Hgb\u201496.5 g\/L, RBC\u20143.97 \u00d7 1012\/L). Laboratory tests were taken to determine the iron deficiency, and transfusion readiness was submitted. The patient received ferric carboxymaltose infusion before surgery. The intraoperative blood loss was\u2014100 mL with an operation duration of 50 min. On the first postoperative day, haemoglobin decreased to 86 g\/L. No haemoglobin decrease was observed in the postoperative period, and 92 g\/L was the amount of haemoglobin at the time of hospital discharge. The optimal dose for the treatment of perioperative anaemia has not been established; some studies recommend ferric carboxymaltose at a dose of 15 to 20 mg\/kg and a maximum of 1000 mg once on the first day after surgery. The uniqueness of this case report is that a high dose of ferric carboxymaltose (1340 mg) during the preoperative period was applied. No side effects such as hypophosphatemia were reported. We believe that, in this clinical case, the patient managed to avoid large intraoperative blood loss and transfusions by using high doses of ferric carboxymaltose.<\/jats:p>","DOI":"10.3390\/medicina60081274","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T08:42:28Z","timestamp":1723020148000},"page":"1274","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: High-Dose Ferric Carboxymaltose as an Antianaemic Agent to Avoid Haemotransfusions after Total Hip Replacement"],"prefix":"10.3390","volume":"60","author":[{"given":"Maiya","family":"Konkayeva","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, National Scientific Center of Traumatology and Orthopaedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan"},{"name":"Department of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6702-657X","authenticated-orcid":false,"given":"Assiya","family":"Kadralinova","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, National Scientific Center of Traumatology and Orthopaedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan"},{"name":"Department of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazerke","family":"Zhanarystan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurlan","family":"Akhatov","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3778-7877","authenticated-orcid":false,"given":"Aidos","family":"Konkayev","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, National Scientific Center of Traumatology and Orthopaedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan"},{"name":"Department of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13018-024-04706-y","article-title":"Impact of preoperative anemia on patients undergoing total joint replacement of lower extremity: A systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_2","first-page":"971","article-title":"Periprosthetic joint infection after artificial joint replacement and preoperative anaemia","volume":"31","author":"Wang","year":"2018","journal-title":"Zhongguo Gu Shang"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/bjs.9861","article-title":"Meta-analysis of the association between preoperative anaemia and mortality after surgery","volume":"102","author":"Fowler","year":"2015","journal-title":"Br. J. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101171","DOI":"10.1016\/j.accpm.2022.101171","article-title":"Effects of ferric carboxymaltose on haemoglobin level after cardiac surgery: A randomized controlled trial","volume":"42","author":"Houry","year":"2023","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/S2352-3026(16)30078-3","article-title":"Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: A prospective, open-label, randomised controlled trial","volume":"3","author":"Khalafallah","year":"2016","journal-title":"Lancet Haematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(18)32555-8","article-title":"Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: A prospective randomised trial","volume":"393","author":"Spahn","year":"2019","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13037-023-00373-w","article-title":"Prevalence and risk factors of preoperative anemia in patients undergoing elective orthopedic procedures in Northwest Ethiopia: A multicenter prospective observational cohort study","volume":"17","author":"Diress","year":"2023","journal-title":"Patient Saf. Surg."},{"key":"ref_8","first-page":"370","article-title":"Pre-operative anaemia: Prevalence, consequences and approaches to management","volume":"13","author":"Campos","year":"2015","journal-title":"Blood Transfus."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/anae.13773","article-title":"International consensus statement on the peri-operative management of anaemia and iron deficiency","volume":"72","author":"Acheson","year":"2017","journal-title":"Anaesthesia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/SLA.0000000000005721","article-title":"Recommendations from the International Consensus Conference on Anaemia Management in Surgical Patients (ICCAMS)","volume":"277","author":"Shander","year":"2023","journal-title":"Ann Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMra1215361","article-title":"Microcytic anaemia","volume":"371","author":"DeLoughery","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-Deficiency Anaemia","volume":"372","author":"Camaschella","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/trf.12195","article-title":"Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: A pooled analysis of observational data from 2547 patients","volume":"54","author":"Cuenca","year":"2014","journal-title":"Transfusion"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13643-021-01579-8","article-title":"Role of preoperative intravenous iron therapy to correct anaemia before major surgery: A systematic review and meta-analysis","volume":"10","author":"Elhenawy","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0971-4065.144421","article-title":"The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study","volume":"25","author":"Vikrant","year":"2015","journal-title":"Indian J. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s40264-022-01216-w","article-title":"High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment","volume":"45","author":"Boots","year":"2022","journal-title":"Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40265-018-0885-7","article-title":"Ferric Carboxymaltose: A Review in Iron Deficiency","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/bcp.14643","article-title":"Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside\u2014A systematic review and meta-analysis","volume":"87","author":"Schaefer","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4055\/cios.2018.10.1.20","article-title":"Postoperative Intravenous Ferric Carboxymaltose Reduces Transfusion Amounts after Orthopedic Hip Surgery","volume":"10","author":"Kim","year":"2018","journal-title":"Clin. Orthop. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/clinem\/dgab852","article-title":"Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose","volume":"107","author":"Schaefer","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bernabeu-Wittel, M., Aparicio, R., Romero, M., Murcia-Zaragoza, J., Monte-Secades, R., Rosso, C., Montero, A., Ruiz-Cantero, A., and Melero-Bascones, M. (2012). PAHFRAC-01 investigators. Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: A randomized contolled trial. The PAHFRAC-01 project. BMC Musculoskelet. Disord., 13.","DOI":"10.1186\/1471-2474-13-27"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"bcr2017222851","DOI":"10.1136\/bcr-2017-222851","article-title":"Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration","volume":"2018","author":"Klein","year":"2018","journal-title":"BMJ Case Rep."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1274\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:17Z","timestamp":1760110277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["medicina60081274"],"URL":"https:\/\/doi.org\/10.3390\/medicina60081274","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}